United Therapeutics Corporation Detailed Financials

Full historical quarterly statements

Metric2026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-30
Total Revenue781.5M790.2M799.5M798.6M794.4M735.9M748.9M714.9M
Cost of Goods Sold133.4M103.4M100.9M87.6M92.5M75.9M83.1M77.8M
Gross Profit648.1M686.8M698.6M711.0M701.9M660.0M665.8M637.1M
R&D Expenses138.2M139.5M127.5M134.0M149.0M133.8M103.5M139.6M
Operating Expenses322.3M329.3M309.3M346.5M319.1M302.3M322.7M317.2M
Operating Income325.8M357.5M389.3M364.5M382.8M357.7M343.1M319.9M
Other Income / Gains-7.5M86.5M48.7M43.9M40.7M38.8M45.5M35.4M
Net Income274.9M364.3M338.7M309.5M322.2M301.3M309.1M278.1M
EPS (Diluted)6.328.367.736.867.186.746.936.26
Reported CurrencyUSDUSDUSDUSDUSDUSDUSDUSD
Gross Profit Ratio0.8290.8690.8740.890.8840.8970.8890.891
General And Administrative Expenses0157.1M153.5M159.8M143.5M135.5M198.5M152.2M
Selling And Marketing Expenses032.7M28.3M31.0M26.6M27.0M20.7M25.4M
Selling General And Administrative Expenses184.1M189.8M181.8M190.8M170.1M162.5M219.2M177.6M
Other Expenses00021.7M06.0M00
Cost And Expenses455.7M432.7M410.2M434.1M411.6M378.2M405.8M395.0M
Interest Income41.8M43.2M46.4M51.3M51.1M49.3M49.8M46.2M
Interest Expense3.0M3.1M3.0M7.3M6.1M7.9M10.1M11.6M
Depreciation And Amortization22.6M22.8M21.9M21.1M-34.6M19.7M19.1M18.7M
Ebitda348.4M469.9M462.9M436.8M382.8M424.1M417.8M338.6M
Ebitdaratio0.4460.5950.5790.5470.4820.5760.5580.474
Operating Income Ratio0.4170.4520.4870.4560.4820.4860.4580.447
Income Before Tax318.3M444.0M438.0M408.4M423.5M396.5M388.6M355.3M
Income Before Tax Ratio0.4070.5620.5480.5110.5330.5390.5190.497
Income Tax Expense43.4M79.7M99.3M98.9M101.3M95.2M79.5M77.2M
Net Income Ratio0.3520.4610.4240.3880.4060.4090.4130.389
Epsdiluted5.827.667.166.416.636.196.395.85
Weighted Average Shs Out43.5M44.3M43.8M45.1M44.9M45.2M44.6M44.4M
Weighted Average Shs Out Dil47.2M47.9M47.3M48.3M48.6M48.7M48.4M47.5M